Cash and Liquidity Position
Ended FY2025 with approximately $20,000,000 of readily available liquid cash and investments, providing runway to fund growth and no stated going concern issues.
Strategic Move into In-House Manufacturing
Announced development of Hangzhou manufacturing plant and shift from fully outsourced model to building in-house capabilities to capture IP, improve unit economics, and enable strategic pricing for high-value applications; buildout progressing with expectation to be operational in 2026.
New Machine Platform and IP Initiatives
Introduced 'Liquid Morphium' advanced injection molding machine and established an IP holding company (Liquid Morphium LLC) to capture newly developed process and tooling intellectual property.
Leadership and Operational Expertise
Professor Lugee Li appointed head of Asia operations and fully devoted to Liquidmetal; brings proven manufacturing track record (founder/former Chairman of Eontec) and operational network to mobilize Hangzhou plant and collaborators.
Customer and Market Traction
Completed prototypes for a top-tier mobile device company and reported current production orders in the medical device space; Yeehaw (outsourced partner) has achieved tier-one vendor status for a global mobile device company and mobile device companies in China.
Corporate Real Estate Upside
Corporate office has a market value reported as more than double its current book value of $7,000,000 (i.e., >100% above book), providing potential additional collateral or liquidity sources.
Clear Strategic Rationale
Management articulated clear objectives for manufacturing: develop proprietary IP, reduce costs at scale to improve gross margins, and attract tier-one manufacturing partners to accelerate customer access.